Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains. - Wang S; Chan KW; Wei D; Ma X; Liu S; Hu G; Park S; Pan R; Gu Y; Nazzari AF; Olia AS; Xu K; et al. (Nature communications, 2024)